Serum levels of FGF23, a phosphaturic hormone that suppresses 1,25(OH)2-vitamin D3 production in kidneys [24], increase early in the course of CKD and reach levels that are several hundred times the normal range in patients with advanced CKD and end-stage renal disease (ESRD) [2]. Here, FGF23 is linked to chronic kidney disease.